Target intelligence / Profile preview

MYC binding protein 2 pseudogene

Molecular classification
Pseudogene
01

Overview

MYC binding protein 2 pseudogene (ENSG00000249486) is a processed or unprocessed pseudogene related to the protein-coding gene "MYC binding protein 2" (MYCBP2, also known as PAM or E3 ubiquitin protein ligase)[4][5]. Pseudogenes like this are characterized by sequence similarity to protein-coding genes but contain mutations or other defects (such as stop codons or frameshifts) that prevent them from producing functional proteins[5][1][3]. While some pseudogenes can influence gene expression in rare instances (such as through competing endogenous RNA mechanisms), there is no evidence that this pseudogene acts as a functional gene or therapeutic target[5][3][1]. Clarification: - The functional gene MYCBP2 is an E3 ubiquitin ligase involved in axon guidance, synapse formation, and protein degradation by ubiquitination[4]. - The pseudogene form, i.e., "MYC binding protein 2 pseudogene" (ENSG00000249486), does not encode a functional protein and is not associated with known biological activities, disease mechanisms, or pharmacological targeting[5][1][3].

Other names
MYCBP2 pseudogeneMYC binding protein 2, pseudogene

Beyond the preview

Go deeper on MYC binding protein 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYC binding protein 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call